BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Immunotherapy
1
Programmed cell death 1 inhibitor sintilimab plus S-1 and gemcitabine for liver metastatic pancreatic ductal adenocarcinoma
12/11/2024 10:19:43 AM | Browse: 52 | Download: 337
2
Immunotherapy for metastatic gastric cancer
10/30/2024 2:58:47 PM | Browse: 68 | Download: 249
3
Impact of liver metastasis on immunotherapy in gastric carcinoma
9/28/2024 4:34:19 AM | Browse: 78 | Download: 266
4
Immunotherapy for gastric cancer and liver metastasis: Is it time to bid farewell
8/16/2024 3:30:03 PM | Browse: 111 | Download: 288
5
Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors
8/16/2024 8:03:14 AM | Browse: 120 | Download: 323
6
Impact of immunotherapy on liver metastasis
7/22/2024 11:57:17 AM | Browse: 121 | Download: 281
7
Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma
7/16/2024 6:17:55 AM | Browse: 123 | Download: 362
8
Managing immune checkpoint inhibitor-associated gastritis: Insights and strategies
6/25/2024 10:41:21 AM | Browse: 105 | Download: 342
9
Comparative effectiveness of immunotherapy and chemotherapy in patients with metastatic colorectal cancer stratified by microsatellite instability status
4/22/2024 9:51:56 AM | Browse: 132 | Download: 433
10
Immune checkpoint inhibitor-associated gastritis: Patterns and management
4/12/2024 4:45:44 PM | Browse: 156 | Download: 507
11
Approaches and challenges in cancer immunotherapy pathways
3/22/2024 11:48:13 AM | Browse: 151 | Download: 439
12
Revolutionizing gastric cancer treatment: The potential of immunotherapy
1/26/2024 7:56:28 AM | Browse: 259 | Download: 614
13
Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023)
10/27/2023 3:28:49 PM | Browse: 294 | Download: 1107
14
Progress in immunotherapy for neuroendocrine neoplasm of the digestive system
7/10/2023 8:58:21 AM | Browse: 272 | Download: 789
15
Immunotherapy for advanced gastric cancer
6/20/2023 11:28:13 AM | Browse: 309 | Download: 777
16
Low-dose immunotherapy as a potentiator to increase the response with neo-adjuvant chemotherapy in oral cancers
6/12/2023 8:16:26 AM | Browse: 277 | Download: 633
17
Immunotherapy for recurrent hepatocellular carcinoma
4/14/2023 1:45:13 PM | Browse: 306 | Download: 736
18
“Cold” colorectal cancer faces a Bottleneck in immunotherapy
2/15/2023 12:44:08 AM | Browse: 323 | Download: 766
19
Conversion therapy for advanced penile cancer with tislelizumab combined with chemotherapy: A case report and review of literature
11/23/2022 9:44:45 AM | Browse: 335 | Download: 1101
20
Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review
11/21/2022 4:25:35 AM | Browse: 444 | Download: 896
21
Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation
11/17/2022 4:40:53 AM | Browse: 536 | Download: 1193
22
Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy
11/10/2022 9:21:28 AM | Browse: 426 | Download: 1210
23
Favorable response of primary pulmonary lymphoepithelioma-like carcinoma to sintilimab combined with chemotherapy: A case report
10/27/2022 4:55:05 AM | Browse: 399 | Download: 980
24
Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China
10/27/2022 4:55:05 AM | Browse: 504 | Download: 1195
25
Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
10/27/2022 3:05:58 AM | Browse: 374 | Download: 1239
26
Longest survival with primary intracranial malignant melanoma: A case report and literature review
10/21/2022 2:24:59 AM | Browse: 409 | Download: 989
27
Hypophysitis induced by anti-programmed cell death protein 1 immunotherapy in non-small cell lung cancer: Three case reports
10/21/2022 2:24:59 AM | Browse: 410 | Download: 996
28
Autoimmune encephalitis with posterior reversible encephalopathy syndrome: A case report
10/21/2022 2:24:59 AM | Browse: 400 | Download: 930
29
Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma
10/14/2022 12:54:50 PM | Browse: 474 | Download: 1785
30
New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
10/14/2022 8:30:45 AM | Browse: 441 | Download: 1028
31
Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
9/29/2022 9:17:29 AM | Browse: 435 | Download: 981
32
Malignant peritoneal mesothelioma with massive ascites as the first symptom: A case report
9/27/2022 1:00:18 PM | Browse: 830 | Download: 1132
33
Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma
9/23/2022 10:13:16 AM | Browse: 465 | Download: 1129
34
Neoadjuvant immunotherapy in non-small-cell lung cancer: Times are changing—and fast
9/22/2022 6:32:13 AM | Browse: 400 | Download: 933
35
Successful treatment of stage IIIB intrahepatic cholangiocarcinoma using neoadjuvant therapy with the PD-1 inhibitor camrelizumab: A case report
9/16/2022 11:52:44 AM | Browse: 419 | Download: 988
36
Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer
9/9/2022 12:48:14 PM | Browse: 440 | Download: 1547
37
Implication of gut microbiome in immunotherapy for colorectal cancer
9/9/2022 12:48:14 PM | Browse: 428 | Download: 1237
38
Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
9/9/2022 12:48:14 PM | Browse: 444 | Download: 1066
39
Advances in postoperative adjuvant therapy for primary liver cancer
9/9/2022 12:48:14 PM | Browse: 477 | Download: 1316
40
Treatment of gastric carcinoma with lymphoid stroma by immunotherapy: A case report
8/26/2022 9:54:53 AM | Browse: 452 | Download: 1361
41
Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma
8/26/2022 9:51:35 AM | Browse: 403 | Download: 935
42
Paroxysmal speech disorder as the initial symptom in a young adult with anti-N-methyl-D-aspartate receptor encephalitis: A case report
8/16/2022 1:35:32 AM | Browse: 358 | Download: 966
43
Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”
8/1/2022 9:20:54 AM | Browse: 493 | Download: 1258
44
Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
7/27/2022 2:48:53 AM | Browse: 496 | Download: 973
45
Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities
7/27/2022 2:48:53 AM | Browse: 433 | Download: 854
46
Short term safety of coronavirus disease 2019 vaccines in patients with solid tumors receiving systemic therapy
7/22/2022 9:38:18 AM | Browse: 519 | Download: 1211
47
Nanomedicine approaches for treatment of hematologic and oncologic malignancies
7/22/2022 9:38:18 AM | Browse: 492 | Download: 1099
48
Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
7/18/2022 9:47:46 AM | Browse: 563 | Download: 1085
49
Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report
7/11/2022 8:36:01 AM | Browse: 405 | Download: 1177
50
Advances and effectiveness of the immunotherapy after liver transplantation
6/27/2022 9:34:47 AM | Browse: 511 | Download: 1169
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345